Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BeOne Medicines Ltd. Director's Dealing 2022

Dec 30, 2022

30073_dirs_2022-12-29_da62e5e7-5422-4a34-aa2b-6a31076c3116.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BeiGene, Ltd. (BGNE)
CIK: 0001651308
Period of Report: 2022-12-27

Reporting Person: OYLER JOHN (Director, Chief Executive Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-12-27 American Depositary Shares S 1120 $224.2934 Disposed 0 Direct
2022-12-27 American Depositary Shares S 1120 $224.2936 Disposed 0 Indirect
2022-12-27 American Depositary Shares S 1119 $224.2935 Disposed 0 Indirect
2022-12-28 American Depositary Shares S 367 $224.7252 Disposed 0 Direct
2022-12-28 American Depositary Shares S 366 $224.7252 Disposed 0 Indirect
2022-12-28 American Depositary Shares S 367 $224.7252 Disposed 0 Indirect
2022-12-29 American Depositary Shares S 1625 $224.423 Disposed 91 Direct
2022-12-29 American Depositary Shares S 91 $225.1308 Disposed 0 Direct
2022-12-29 American Depositary Shares S 1625 $224.4227 Disposed 92 Indirect
2022-12-29 American Depositary Shares S 92 $225.1296 Disposed 0 Indirect
2022-12-29 American Depositary Shares S 1625 $224.4228 Disposed 92 Indirect
2022-12-29 American Depositary Shares S 92 $225.1297 Disposed 0 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Ordinary Shares 1704274 Direct
Ordinary Shares 481533 Indirect
Ordinary Shares 7727927 Indirect
Ordinary Shares 29072476 Indirect
Ordinary Shares 9633361 Indirect
Ordinary Shares 102188 Indirect

Footnotes

F1: These securities are held by the P&O Trust, the beneficiaries of which include the Reporting Person's child and others, for which the Reporting Person disclaims beneficial ownership.

F2: These securities are held in a grantor retained annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership.

F3: These securities are held by Oyler Investment LLC, of which 99% of the limited liability company interest is owned by a grantor retained annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership.

F4: These securities are held for the benefit of the Reporting Person in a Roth IRA PENSCO trust account.

F5: These securities are held by The John Oyler Legacy Trust, of which the Reporting Person's father is a trustee, for the benefit of the Reporting Person's minor child, for which the Reporting Person disclaims beneficial ownership.

F6: Each American Depositary Share represents 13 Ordinary Shares.

F7: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 13, 2022.

F8: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $224.00 to $224.76, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

F9: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on March 7, 2022.

F10: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $224.00 to $224.94, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

F11: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $225.02 to $225.43, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.